Jiangsu Hengrui Medicine (600276.SS) Earnings Analysis
Jiangsu Hengrui Medicine (600276.SS) next reports earnings on 2026-08-20, consensus EPS 0.3717 CNY. Last quarter (2026-04-22) it beat with EPS 0.3369 CNY vs 0.3275 CNY est (+2.9%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 43.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600276.SS next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | 0.3717 CNY |
| Revenue estimate | 9.02B |
600276.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.3369 CNY | 0.3275 CNY | +2.9% | Beat |
| 2026-03-25 | 0.3063 CNY | 0.3414 CNY | -10.3% | Miss |
| 2025-10-23 | 0.1999 CNY | 0.2958 CNY | -32.4% | Miss |
| 2025-08-20 | 0.3974 CNY | 0.3129 CNY | +27% | Beat |
| 2025-05-30 | 0.29 CNY | 0.2925 CNY | -0.9% | Miss |
| 2024-12-31 | 0.2707 CNY | 0.21 CNY | +28.9% | Beat |
| 2024-10-24 | 0.19 CNY | 0.23 CNY | -17.4% | Miss |
| 2024-08-21 | 0.33 CNY | 0.33 CNY | 0% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
600276.SS valuation and analyst view
| Trailing P/E | 43.93 |
|---|---|
| Trailing EPS | 1.231 CNY |
| Price / book | 5.69 |
| Dividend yield | 0.36% |
| Market cap | 353.33B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jiangsu Hengrui Medicine (600276.SS)'s next earnings date?
Jiangsu Hengrui Medicine is next scheduled to report on 2026-08-20, with a consensus EPS estimate of 0.3717 CNY and revenue estimate of 9.02B.
Did 600276.SS beat earnings last quarter?
In its 2026-04-22 report, 600276.SS posted EPS of 0.3369 CNY versus a 0.3275 CNY estimate — a beat of 2.9%.
What is 600276.SS's earnings track record?
Over the last 8 reported quarters with consensus data, 600276.SS beat estimates 4 times (50%).
What is 600276.SS's current P/E ratio and EPS?
600276.SS trades at a trailing P/E of 43.93 on trailing EPS of 1.2305598766115993 CNY.
What do analysts rate 600276.SS?
600276.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.